Brief: Coherus Oncology Q3 Sales USD 11.571 Million Vs. IBES Estimate USD 13.4 Million
06/11/2025 21:14
Nov 06 (Reuters) - Coherus Oncology Q3 net income USD -35.531 million. Q3 adjusted net income USD -38.897 million vs. IBES estimate USD -33.5 million Q3 operating income USD -44.333 million
Recent news on Coherus Oncology
See all newsBrief: Coherus Oncology Initiates Process To Sell Legacy Biosim Assets
Brief: Coherus Oncology Announces Special Dividend Of Biosimilar Contingent Value Rights
Coherus Oncology Inc reports results for the quarter ended June 30 - Earnings Summary
Coherus Oncology Q2 revenue rises 40% on higher LOQTORZI volume, but slightly falls below estimates
Brief: Coherus Oncology Q2 Net Income USD -20.631 Million